901 - 950 of 9030 Results
Title
Year
- The immune system in Parkinson’s disease: what we know so far2024OPENTitle: The immune system in Parkinson’s disease: what we know so farJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awae177Citation Count: 0
- Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA Sequencing2024OPENTitle: Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA SequencingJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 61Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-024-04124-5Citation Count: 2
- A framework for translational therapy development in deep brain stimulation2024OPENTitle: A framework for translational therapy development in deep brain stimulationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00829-5Citation Count: 0
- The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapses2024OPENTitle: The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapsesJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 87Issue #:Start Page: 102886End Page: 102886Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.conb.2024.102886Citation Count: 1
- The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysis2024RESTRICTEDTitle: The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysisJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 459Issue #:Start Page: 122970End Page: 122970Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2024.122970Citation Count: 0
- Disease-Modifying Therapies in Parkinson’s Disease2025RESTRICTEDTitle: Disease-Modifying Therapies in Parkinson’s DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 43Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2024.12.009Citation Count: 0
- Fanning the Flames in Anti-N-methyl-D-aspartate Receptor Encephalitis2015RESTRICTEDTitle: Fanning the Flames in Anti-N-methyl-D-aspartate Receptor EncephalitisJournal Name: International Journal of Gynecological PathologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 401End Page: 402Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/pgp.0000000000000186Citation Count: 0
-
OPENTitle: A Spatiotemporal Map of the Aging Mouse Brain Reveals White Matter Tracts as Vulnerable FociJournal Name: SSRN Electronic JournalPublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2139/ssrn.4260648Best OA location URL: https://doi.org/10.1101/2022.09.18.508419Citation Count: 2
-
OPENTitle: Sedation and sleep safety of pimavanserin for Parkinsons’s disease psychosis: Review and exploratory analysis of clinical study dataJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100342End Page: 100342Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100342Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100342Citation Count: 0
- Stride width and postural stability in frontal gait disorders and Parkinson’s disease2024RESTRICTEDTitle: Stride width and postural stability in frontal gait disorders and Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 271Issue #: 7Start Page: 3721End Page: 3730Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-024-12401-5Citation Count: 4
- Position paper: leveraging non-human primate (NHP) specificities to accelerate Parkinson’s disease and ageing research2025OPENTitle: Position paper: leveraging non-human primate (NHP) specificities to accelerate Parkinson’s disease and ageing researchJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01088-8Citation Count: 0
-
RESTRICTEDTitle: Adaptive immunity in the pathogenesis and treatments of Parkinson’s diseaseJournal Name: NeuroImmune Pharmacology and TherapeuticsPublisher: Walter de Gruyter GmbHVol: 4Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1515/nipt-2025-0008Best OA location URL: https://www.degruyterbrill.com/document/doi/10.1515/nipt-2025-0008/pdfCitation Count: 0
-
OPENTitle: Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical TranslationJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 15Start Page: 1161End Page: 1161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14151161Best OA location URL: https://www.mdpi.com/2073-4409/14/15/1161/pdf?version=1753706875Citation Count: 0
- Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding2019RESTRICTEDTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable risk2018RESTRICTEDTitle: Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable riskJournal Name:Publisher:Vol:Issue #:Start Page: 388165End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 4
- Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)2019RESTRICTEDTitle: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Finding useful biomarkers for Parkinson's disease2018RESTRICTEDTitle: Finding useful biomarkers for Parkinson's diseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)2014RESTRICTEDTitle: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 2
- Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)2018RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)2017RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)2019RESTRICTEDTitle: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Validation of Fox Insight Cohort via Virtual Research Visits (4749)2020RESTRICTEDTitle: Validation of Fox Insight Cohort via Virtual Research Visits (4749)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activity2020RESTRICTEDTitle: Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activityJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 1
- Novel therapeutic approaches to target neurodegeneration2022RESTRICTEDTitle: Novel therapeutic approaches to target neurodegenerationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/au.167164898.84768756Citation Count: 0
- Ethical and Responsible Use of AI/ML in the Earth, Space, and Environmental Sciences2023RESTRICTEDTitle: Ethical and Responsible Use of AI/ML in the Earth, Space, and Environmental SciencesJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/essoar.168132856.66485758Citation Count: 1
- Journal Production Guidance for Software and Data Citations2022RESTRICTEDTitle: Journal Production Guidance for Software and Data CitationsJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/essoar.167252601.17695321Citation Count: 0
- Automatic Facial Landmark Localization in Clinical Populations - Improving Model Performance with a Small Dataset2020RESTRICTEDTitle: Automatic Facial Landmark Localization in Clinical Populations - Improving Model Performance with a Small DatasetJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.21203/rs.3.rs-19405Citation Count: 3
- Neurochemical biomarkers in the differential diagnosis of movement disorders2009RESTRICTEDTitle: Neurochemical biomarkers in the differential diagnosis of movement disordersJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 10Start Page: 1411End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22510Citation Count: 43
- Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases2022RESTRICTEDTitle: Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseasesJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 1Start Page: 101478End Page: 101478Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101478Best OA location URL: http://www.jbc.org/article/S0021925821012874/pdfCitation Count: 19
-
RESTRICTEDTitle: Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammationJournal Name: Seminars in ImmunopathologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 6Start Page: 681End Page: 696Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00281-020-00819-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00281-020-00819-8.pdfCitation Count: 10
-
RESTRICTEDTitle: Inflammation in Experimental Models of α‐SynucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 37End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28264Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115204Citation Count: 24
- Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy2021RESTRICTEDTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name:Publisher:Vol:Issue #:Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162;Citation Count: 9
-
RESTRICTEDTitle: Application of deep learning in detecting neurological disorders from magnetic resonance images: a survey on the detection of Alzheimer’s disease, Parkinson’s disease and schizophreniaJournal Name: Brain InformaticsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40708-020-00112-2Best OA location URL: https://braininformatics.springeropen.com/track/pdf/10.1186/s40708-020-00112-2Citation Count: 182
- Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 Mutation2021RESTRICTEDTitle: Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 MutationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13296;Citation Count: 1
- High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease2021RESTRICTEDTitle: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s diseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1186/s40478-021-01282-8;Citation Count: 68
- Mitochondrial isolation: when size matters2020RESTRICTEDTitle: Mitochondrial isolation: when size mattersJournal Name:Publisher:Vol:Issue #:Start Page: 226End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.12688/wellcomeopenres.16300.1;Citation Count: 3
- Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development2019RESTRICTEDTitle: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentJournal Name:Publisher:Vol:Issue #:Start Page: 216847901881751End Page: 216847901881751Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/2168479018817517;Citation Count: 21
- Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro2020RESTRICTEDTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name:Publisher:Vol:Issue #:Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866;Citation Count: 9
-
RESTRICTEDTitle: Growth Factor Therapy for Parkinson’s Disease: Alternative Delivery SystemsJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s2Start Page: S229End Page: S236Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212662Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212662?id=journal-of-parkinsons-disease%2Fjpd212662Citation Count: 6
-
RESTRICTEDTitle: A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative StudiesJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 6Start Page: 1703End Page: 1725Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212986Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212986?id=journal-of-parkinsons-disease%2Fjpd212986Citation Count: 5
- Developing new treatments in partnership for primary mitochondrial disease: What does industry need from academics, and what do academics need from industry?2020RESTRICTEDTitle: Developing new treatments in partnership for primary mitochondrial disease: What does industry need from academics, and what do academics need from industry?Journal Name: Journal of Inherited Metabolic DiseasePublisher: WileyVol: 44Issue #: 2Start Page: 301End Page: 311Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/jimd.12326Citation Count: 2
-
RESTRICTEDTitle: Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta‐analysisJournal Name: ESC Heart FailurePublisher: WileyVol: 8Issue #: 6Start Page: 5466End Page: 5481Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ehf2.13648Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712892Citation Count: 16
-
RESTRICTEDTitle: “LRRK2: Autophagy and Lysosomal Activity”Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00498Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00498/pdfCitation Count: 84
-
RESTRICTEDTitle: Defining research priorities in dystoniaJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 12Start Page: 526End Page: 537Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009140Best OA location URL: https://europepmc.org/articles/pmc7274927?pdf=renderCitation Count: 27
-
RESTRICTEDTitle: Research criteria for the diagnosis of prodromal dementia with Lewy bodiesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 17Start Page: 743End Page: 755Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000009323Best OA location URL: https://n.neurology.org/content/neurology/94/17/743.full.pdfCitation Count: 373
-
RESTRICTEDTitle: Association between Various Brain Pathologies and Gait DisturbanceJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 43Issue #: 3-4Start Page: 128End Page: 143Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000456541Best OA location URL: https://www.karger.com/Article/Pdf/456541Citation Count: 45
-
RESTRICTEDTitle: Fundamentals of transcranial electric and magnetic stimulation dose: Definition, selection, and reporting practicesJournal Name: Brain StimulationPublisher: Elsevier BVVol: 5Issue #: 4Start Page: 435End Page: 453Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2011.10.001Best OA location URL: https://europepmc.org/articles/pmc3346863?pdf=renderCitation Count: 351
- Psychiatric Drugs Bind to Classical Targets Within Early Exocytotic Pathways: Therapeutic Effects2012RESTRICTEDTitle: Psychiatric Drugs Bind to Classical Targets Within Early Exocytotic Pathways: Therapeutic EffectsJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 72Issue #: 11Start Page: 907End Page: 915Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2012.05.020Best OA location URL: https://europepmc.org/articles/pmc6167061?pdf=renderCitation Count: 49
- The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases2009RESTRICTEDTitle: The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseasesJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Cell ResearchPublisher: Elsevier BVVol: 1793Issue #: 9Start Page: 1496End Page: 1507Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbamcr.2009.01.016Best OA location URL: https://doi.org/10.1016/j.bbamcr.2009.01.016Citation Count: 156